NCPDP SCRIPT for electronic prescription routing and NCPDP D.0 for adjudicating claims with PBMs — bridged with PharmaNet (BC), Infoway PrescribeIT, and real-time prescription benefit checks.
The full NCPDP toolkit for retail and clinical pharmacy — in production with PBMs, prescribers, and provincial drug systems today.
Inbound and outbound electronic prescriptions, refills, cancellations, and change requests — on the current SCRIPT standards.
Real-time adjudication with PBMs, real-time benefit transparency at the point of prescribing, and post-adjudication reconciliation.
Bridging NCPDP to Canadian provincial drug systems and Infoway's national e-prescription network for cross-border and Canadian workflows.
Six standards and regulatory shifts reshaping pharmacy EDI roadmaps in 2026.
NCPDP SCRIPT version 2023011 is the current standard, adding richer support for REMS, specialty drug enrollment, and structured patient-supplied medication history. CMS Medicare Part D is moving the floor off 2017071 — expect a 2026–2027 mandate window.
The DEA's EPCS requirement for controlled-substance prescriptions is in full effect for Medicare Part D and is expanding state-by-state for Medicaid in 2026. SCRIPT 2017071+ with two-factor identity proofing is now table stakes for any prescriber and any pharmacy handling controlled substances.
The CMS RTPB requirement for Medicare Part D prescribers is now standard practice across most EMR/eRx vendors. Patients see their actual out-of-pocket cost at the point of prescribing — reducing abandonment, lifting adherence, and cutting "sticker shock" callbacks to pharmacies.
Infoway's PrescribeIT continues its province-by-province rollout in Canada in 2026 with expanding integrations across community pharmacy software and EMRs. For multi-province operators, a single integration to PrescribeIT covers a growing share of national volume.
The Inflation Reduction Act's Medicare Part D redesign and DIR-fee reforms continue reshaping PBM economics in 2026. Claim-level fee disclosures and post-adjudication reconciliation are now critical for pharmacy margin management — with EDI as the only practical audit trail.
HRSA and major manufacturers are tightening 340B claim-level transparency requirements in 2026. Covered entities and contract pharmacies face stricter audit trails on which 340B-discounted units were dispensed to eligible patients — pushing structured claim and dispensing data into mandatory monthly reports.
Service Points runs the full prescription lifecycle against your pharmacy system, PBM connections, and provincial drug rails.
The prescriber sends a SCRIPT NewRx; it lands in the pharmacy queue with structured drug, sig, refill, and prior-auth flags — no fax to retype.
Real-time benefit lookup returns the patient's actual cost, the preferred alternative, and any PA requirement — before the tech starts the fill.
NCPDP D.0 claim hits the PBM. Approval, DUR alerts, and any rejections come back in seconds with the corrective action mapped.
For Canadian fills, PharmaNet / PrescribeIT / provincial DIS records update automatically — no manual data entry, no missed entries that violate provincial requirements.
Service Points pharmacy EDI clients consistently report these gains within the first two months.
Book a 30-minute pharmacy EDI assessment. We'll trace one prescription end-to-end on our platform — eRx in, claim adjudicated, PharmaNet logged.